 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

For the last three days, A.I.dvisor has detected that AXGN's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Axogen (AXGN, $8.07) Aroon Indicator entered a Downtrend on March 28, 2024.

This indicator may be signaling AXGN's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Axogen (AXGN, $8.07) entered Uptrend as Momentum indicator ascends above 0 level on Mar 28, 2024

AxoGen, Inc. (NASDAQ:AXGN  Get Free Report) CEO Karen L. Zaderej sold 39,280 shares of the businesss stock in a transaction that occurred on Thursday, March 21st. The shares were sold...

AxoGen, Inc. (NASDAQ:AXGN) CEO Karen L. Zaderej Sells 39,280 Shares

Axogen (AXGN, $7.77) Aroon Indicator entered a Downtrend on March 27, 2024.

This is a signal that AXGN's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Axogen (AXGN, $7.77) RSI Indicator left the oversold zone on March 27, 2024

AxoGen, Inc. (NASDAQ:AXGN  Get Free Report) VP Michael Patrick Donovan sold 6,033 shares of the firms stock in a transaction dated Thursday, March 21st. The stock was sold at an average...

AxoGen, Inc. (NASDAQ:AXGN) VP Michael Patrick Donovan Sells 6,033 Shares

AxoGen, Inc. (NASDAQ:AXGN  Get Free Report) VP Michael Patrick Donovan sold 6,033 shares of the companys stock in a transaction that occurred on Thursday, March 21st. The shares were...

AxoGen, Inc. (NASDAQ:AXGN) VP Sells $46,333.44 in Stock

Harbor Capital Advisors Inc. lessened its position in shares of AxoGen, Inc. (NASDAQ:AXGN  Free Report) by 35.6% during the 4th quarter, according to its most recent Form 13F filing with the...

Harbor Capital Advisors Inc. Has $107,000 Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN)

AxoGen, Inc. (NASDAQ:AXGN  Free Report)  Investment analysts at Cantor Fitzgerald decreased their FY2024 earnings per share estimates for shares of AxoGen in a research note issued to...

Cantor Fitzgerald Comments on AxoGen, Inc.'s FY2024 Earnings (NASDAQ:AXGN)

Axogen (AXGN, $8.75) RSI Indicator left the oversold zone on March 08, 2024

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Volume (M)	123,937.00
52-Wk High	$10.83
52-Wk Low	$3.45

AXGN Axogen Inc.

About

Feed

News

Sentiment

Earnings

Fundamentals